Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ViewRay (VRAY)

ViewRay Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VRAY
DateTimeSourceHeadlineSymbolCompany
07/09/202322:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRAYViewRay Inc
03/08/202321:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRAYViewRay Inc
26/07/202322:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRAYViewRay Inc
26/07/202322:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRAYViewRay Inc
26/07/202322:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VRAYViewRay Inc
26/07/202322:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VRAYViewRay Inc
21/07/202321:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VRAYViewRay Inc
21/07/202321:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRAYViewRay Inc
21/07/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRAYViewRay Inc
21/07/202321:01PR Newswire (US)ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC MarketsNASDAQ:VRAYViewRay Inc
20/07/202322:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRAYViewRay Inc
19/07/202321:53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRAYViewRay Inc
19/07/202320:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRAYViewRay Inc
18/07/202321:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRAYViewRay Inc
17/07/202312:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRAYViewRay Inc
17/07/202312:00PR Newswire (US)ViewRay® Files Voluntary Chapter 11 PetitionsNASDAQ:VRAYViewRay Inc
07/07/202321:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRAYViewRay Inc
30/06/202321:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRAYViewRay Inc
16/06/202321:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRAYViewRay Inc
16/06/202321:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRAYViewRay Inc
13/06/202311:00PR Newswire (US)VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy SystemNASDAQ:VRAYViewRay Inc
26/05/202321:14Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:VRAYViewRay Inc
12/05/202311:30PR Newswire (US)ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology MeetingNASDAQ:VRAYViewRay Inc
10/05/202321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRAYViewRay Inc
10/05/202321:01PR Newswire (US)ViewRay Announces First Quarter 2023 ResultsNASDAQ:VRAYViewRay Inc
09/05/202321:10PR Newswire (US)ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023NASDAQ:VRAYViewRay Inc
28/04/202322:29Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:VRAYViewRay Inc
13/04/202311:51Dow Jones NewsViewRay Hires Adviser to Evaluate Strategic AlternativesNASDAQ:VRAYViewRay Inc
13/04/202311:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRAYViewRay Inc
13/04/202311:00PR Newswire (US)ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder ValueNASDAQ:VRAYViewRay Inc
 Showing the most relevant articles for your search:NASDAQ:VRAY